Mark R. Bamforth, Sr.VP, Corporate Operations & Phar at GENZYME CORP (GENZ), bought 700 shares at $54.54 ($38K) on 2009-03-04, disclosed to the SEC on 2009-03-06.
Open-market purchase of $38k GENZ by Sr.VP, Corporate Operations & Phar. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CDMO | BUY | 2020-03-16 | $104K | — | Filing → |
| CDMO | BUY | 2018-02-20 | $113K | — | Filing → |
| PPHM | BUY | 2017-10-27 | $444K | — | Filing → |